Búsqueda Imágenes Maps Play YouTube Noticias Gmail Drive Más »
Iniciar sesión
Usuarios de lectores de pantalla: deben hacer clic en este enlace para utilizar el modo de accesibilidad. Este modo tiene las mismas funciones esenciales pero funciona mejor con el lector.

Patentes

  1. Búsqueda avanzada de patentes
Número de publicaciónUS3096560 A
Tipo de publicaciónConcesión
Fecha de publicación9 Jul 1963
Fecha de presentación21 Nov 1958
Fecha de prioridad21 Nov 1958
Número de publicaciónUS 3096560 A, US 3096560A, US-A-3096560, US3096560 A, US3096560A
InventoresWilliam J Liebig
Cesionario originalWilliam J Liebig
Exportar citaBiBTeX, EndNote, RefMan
Enlaces externos: USPTO, Cesión de USPTO, Espacenet
Process for synthetic vascular implants
US 3096560 A
Resumen  disponible en
Imágenes(1)
Previous page
Next page
Reclamaciones  disponible en
Descripción  (El texto procesado por OCR puede contener errores)

July 9, 1963 w. J. LIEBIG 3,096,560

PROCESS FOR SYNTHETIC VASCULAR IMPLANTS Filed Nov. 21, 1958 INVENTOR.

WILLIAM J. LIEBIG AT TOR N EYS United States Patent PROCESS FOR SYNTHETIC VASCULAR IMPLANTS William J. Liebig, Martha Road, Harrington Park, NJ. Filed Nov. 21, 1958, Ser. No. 775,522 3 Claims. (CI. 28-72) This invention concerns vascular prostheses and the manufiacture thereof. It .aims to provide for such devices an improved flexible and resilient self-supporting tubular wall structure which affords a normal open form for the prosthetic tube defined thereby'and in which form it is supple and pliant as to fiexure capacity, is extensible and contractible elastically lengthwise, and has the property of automatic return to the open form with little or no remnant deformation upon release of bending, compressive or other distorting stress.

The invention further includes certain methods and means calculated to provide such vascular prostheses or tubular implants having the stated capacity for fiexure, for elastic longitudinal adjustment and for maintenance in and self-return to normal open tubular shape on release of whatever deforming stress.

The invention is more particularly pertinent to the fabrication of non-sewn tubular woven synthetic vascular implants such as fully disclosed and claimed in my copending application Serial No. 653,562, filed -April 18, 1957 now Patent No. 2,978,787, granted April 11, 1961. It generally improves thereon by correlating with the all-Woven basic tubular body formation thereof a determined lateral and circumferential wall modification presenting a smooth interior and a finely folded exterior structure herein sometimes termed micro-crimping, having (reference both to the method and to the resultant formation.

In the drawings illustrating embodiments of the invention along with certain novel means for practicing the method thereof:

FIG. 1 shows a single-tube woven implant and forming mandrel at an intermediate stage of micro-crimpingg FIG. 2 shows a further stage in the processing, with the implant fully installed on the mandrel and reduced to final normal length;

FIGS. 3 to 6 illustrate the product, method, and means as to a vascular implant of bifurcated form, wherein FIG. 3 shows an intermediate stage corresponding generally to that of FIG. 1;

FIG. 4 represents a further stage like that of FIG. 2;

FIG. 5 shows separately a mandrel such as used for bifurcate implants, with legs thereof demounted;

FIG. 6 on a smaller scale shows the mandrel of FIG. 5 assembled;

FIG. 7 is an elevational view of a length of implant of the invention, such as that of FIG. 2 or 4, with a portion sectioned to show the generally smooth internal wall surface as presented by the multiplicity of narrow closeabutted woven fabric rings thereat; and

FIG. 8 is a partly diagrammatic perspective of an end portion of an implant fabric blank unit such as of FIGS. 1 and 3 before micro-crimping.

Referring to the drawings in more detail the vascular prostheses or implants of this invention are basically fabricated by weaving them in fiat tubular form upon a specially modified Jacquard loom so that a plurality of fine dense fabric plies are interwoven along longitudinal integral union zones, the resultant continuous tubular non-sewn bodies being composed of multi-filament circumferential warp and longitudinal filling strands.

These implants may have various overall for-ms of which two main categories are herein illustrated. FIGS. 1 and 2 show an implant of the single-tube, simple or 'straight line form, designated as a whole at 10. FIGS.

3 and 4 show an important divided, bifurcate or V-form, indicated as a whole at 20.

An implant 10, at an intermediate stage following severance from the larger fabric blank that comes from the loom, is seen at the right in FIG. 1, in more or less flattened or partly open condition, as indicated at 10A and similarly at 20A in FIG. 3, see also FIG. 8. It comprises superposed woven fabric plies 11, 11 integrally joined in longitudinal non-sewn flangedike scams or seal- .formations 12 along diametrically opposite longitudinal portions. These axis-paralleling unions or seal-formations 12 are composite non-sewn integral fabric structures interwoven as part of the tubular implant body as a whole. Each contains a dual-ply fabric area demarked from the adjoined main tubular portion by sealing lines of union where the constituent Warp is cross-shedded, as at S, S and 5, FIG. 8.

As noted, an implant unit such as 10 of FIGS. 1 and 2 is severed from others initially in the same plural-ply woven fabric web. The severance is along a crossshedded line of ply union such as S of FIG. 8, spaced by at least one other such union line fromthe adjoined main tubular area of the fabric; see such lines S and S in FIG. 8. Along the severance line S the component synthetic multi-filament yarns are heat-sealed as by a heated severing instrument to afford a fused seal in addition to the one or more in-woven lines of union contained in the entirety of each of the respective integral longitudinal unions or seal formations 12. The foregoing description of the non-sewn woven tubular fabric along with the present drawings is adequate for the purposes of this application and is as'disclosed in greater detail in my mentioned copending application.

As in said earlier application the woven tubular unit blanks as at 10A and 20A are composed of fine-denier multi-filament synthetic warp and filling yarns of ma terials selected for desired vascular implant properties. These include compatibility with human tissue along with wetta'bility for blood such as to promote the starting of clotting and the attendant growth of a layer of collagen on the wall of the prosthetic tubing after implantation, and further include strength, flexibility and resilience, appropriate water-absorptivity and capacity to withstand sterilization. The multi-filament yarn found most satisfactory to date is a terephthalic acid-ethylene glycol ester ascommercially produced by Du Pont de Nemours Co. under the trademark Dacron. Some of the desired characteristics are present in other commercially available synthetic fibres including the long-chain polyamide type of the nylon class, those of the tetrafiuoroethylene type known under the trademark Teflon, also the type commercially designated as Orlon. In the presently prefer-red example the weaving is accomplished with a 34-filament Dacron yarn of approximately 70 denier as for example that known commercially as Du Pont Type 56 (formerly called 5600), received from the manufacturer with zero twist and preparatorily to weaving .given a relatively soft twist as for example about a 9 to 12 turn left or Z twist for warp and about a 5 turn left 2 or right 8 twist for filling.

In the practice of the invention, wherein the porosity of the fabric is a function both of the size and of the multi-filament nature of the yarns as well as of the close proximity of the yarns as laid in the weaving operation, an extremely close or dense weave of the selected yarns is needed for the relatively low order of porosity here concerned, desirably not less than 16 nor greater than about 25 to 30 porosity in terms of cubic feet of air per minute through a square foot of the fabric at a pressure of 1.26 in. of water. Utilizing as preferred example a 70 denier 34-filament Dacron yarn, suitable fabric fineness, density and porosity is obtained when each cloth or ply of the dual-layer fabric has a count in the order of 150 or more warp ends by 100 or more filling picks per inch in a plain or so-called taffeta weave, the loom generally employing in the two cloths or plies a total of over 300 warp ends by 200* picks per inch, in one example 168 warp ends by 108 filling picks per inch. Further by way of specific example but without limitation thereto a specially modified Jacquard loom in one case of actual practice weaves a 50-inch web incorporating a sheet of 15,360 warp ends appropriately divided for shedding into two warp sets, the integral unions of the fabric plies as above mentioned being accomplished by causing the respective warp sets to cross over as appropriate for the shape and dimension of the particular tubular implant desired.

On the accompanying drawing the multi-filament warp yarns, extending circumferentially of the tube are designated at w and the similar filling yarns, lengthwise of the tube, at 7, FIGS. 1, 3, 7 and 8.

The resultant woven integrally sealed non-sewn tubular elements or implant units as at A and A hereof, following dofiing of the fabric web from the loom and severance of the individual implant units as already described are under the present invention accorded the further processing whereby the finished tubular products incorporate markedly improved characteristics as to lateral flexibility and resilience and axial elastic extension coupled with the capacity of self-support in and selfreturn to open tubular form.

In such processing I employ forming and ironing mandrels of generally cylindrical rod form and of metal or other material adapted for heating and free of objectionable chemical or contaminant effect on the tubular fabric blanks received thereon. Preferred materials include stainless steel and chemically pure anodized aluminum.

For the single-tube form of FIGS. 1 and 2 the mandrel 30 is a straight rod of circular cross-section having at one or both ends a rounded nose as at 31. Each such mandrel 30 is accurately scaled to an outer diameter closely matching the inner diameter for the particular size of implant in the finished inflated or open status. The mandrels, which are provided with a smooth hard outer surface, accordingly are made of lumen-filling dimension with respect to the tubular implant units. Typical examples for the straight or single-tube implants of FIGS. 1 and 2 are as follows:

STRAIGHT TUBES Flat Diameter, mm.

Open Diameter, mm.

The values in the right-hand column under open diameter are the lumen size of the ready-for-use implant in relaxed status. The mandrel diameter at room temperature is closely scaled to the lumen of the particular implant.

Having furnished and selected the appropriate mandrel 30 the woven tubular implant blank 10A preferably moistened in a water bath is passed and collected in a moist state onto the mandrel received snugly within it. The fabric blank is axially compressed on the mandrel 30 so that it is condensed to approximately of the Original length of the blank. This is accomplished mechanically or by hand, the foremost end of the blank being passed along over the mandrel to a distance from the receiving end thereof at least equal to the final condensed length of the implant. In FIG. 1 the blank 10A is shown in progression onto the mandrel and in the course of being compressed. In FIG. 2 the compressive approximate 4:1 length reduction has been completed.

This operation of compressing the moistened fabric blank onto the mandrel creates at the same time a longitudinal array of minute circumferential pleats or crimps 15 upon the tubular fabric wall, shown on an enlarged scale in FIG. 7 and seen more or less diagrammatically in each of FIGS. 1 to 4. These pleats 15 are wholly external to the inner circumferential surface of the tubular implant as compelled by the filling diameter of the forming mandrel 30. Under the stated 4 to l compressive axial reduction the two radial walls of each individual pleat or crimp 15 are approached to each other into largely closed or random touching proximate contiguity, particularly at the basal portions. Also in the longitudinal array as a whole the multiplicity of minute pleats or crimps 15 which I term micro-crimping are closely compacted one with the next in somewhat re-entrant or partially interfitting relation in a closed rank or stack.

Noting particularly FIG. 7, the short pleats or crimps 15 of the multiplicity thereof are of uneven outward radial extent and individually vary in cross-sectional contour. While the outward radial extent of the microcrimping is a function of the diameter of the implant tube and of the mandrel, increasing with the tube diameter, the exact shaping thereof is random and without deliberate mechanical or measured distribution into a certain number of crimps per inch or into absolute regularity in radial extent and area. Otherwise stated, the micro-crimping is that resultant from and characterized by axial compressive reduction of the tubular fabric blank in a moist state to approximately 25 of the original length in conjunction with installation upon a smooth hard-surfaced incompressible mandrel of full scale or filling size equivalent to the desired lumen for the particular tubular implant product.

Further, in the described micro-crimping procedure the plural-ply radially projective longitudinal seal formations 12 automatically accommodate themselves to the close fine pleating 15 of the tube body. They likewise assume a random compressed, pleated or rufiled form with the crests of the pleats some to one side and some to the other side of the original longitudinal line of sealing union along the tube body, in oppositely offset relation with respect to that line, in a manner resembling a positive and negative curve along a zero reference line. Also the fabric of the seal formations 12 is in major part external to the crests of the body pleats 15. Thus these seal formations 12 conform themselves to the same proportionate approximate 4 to 1 length reduction as for the tubular body portion, noting particularly the elevational portion of FIG. 7. These micro-crimped seal zones 12 while imparting little or no decrease in flexibility, lateral resilience or axial elasticity for the resulting tubular implant as a whole, contribute to the overall capacity of the implant for self-maintenance in a normal open condition and for return thereto on removal of deforming force.

Referring again to FIG. 7 showing a completed implant the interior thereof presents a cylindrical surface defined by a multiplicity of uniform-diametered inwardly smooth rings 16 of like number as that of the pleats or crimps 15 and spanning between them in mutually touching side by side relation over the entire longitudinal extent of the implant tube in the normal or relaxed state of the final product. In completing the processing these internal wallrdefining rings 16 are in eifect internally ironed to present a smooth cylindrical Wall surface wholly uninterrupted circumferentially and being effectively closed or continuous longitudinally in the normal unstressed status of the tubular device.

With the tubular fabric unit installed in a moist state and fully compressed to ultimate reduced length as in FIG. 2 or 4, the carrying mandrel 30 or 35 is inserted into an oven Where it is located over a water bath and is heated to a temperature determinately below the melting point of the component synthetic yarns. In the preferred instance of Dacron for example, having a melting point of 480 F., the oven temperature is held to not exceeding about 425 F., the f-abric'thus being subjected to a slightly moist heat over the water bath in the oven. Under this treatment the metallic mandrel 30 tends to expand and accordingly imparts to the inner interpleat rings 16 a further smoothing or ironing action and resultant substantially uniform cylindrical inner surface for the device as a whole. This ironing heat and moisture treatment is of short duration accurately timed for optimum effect. In practice the best timing is found to be approximately 15 minutes, any variation therefrom desirably being not more than about one and one-half minutes plus or minus.

At the end of the controlled heating period the mandrel and micro-crimped implant unit thereon are removed from the oven and placed into a relatively cool Water bath at approximately 70 F. orsubstantially room temperature for a cooling period of about five minutes. This cools and shrinks the mandrel and is believed to have some beneficial adjustive or relaxing efiect upon the com-' ponent synthetic yarns and the multi-filaments thereof. Following the coolant Water bath the implant unit such as of FIGS. 1 and 2 is removed from the mandrel and allowed to dry at room temperature.

The process as above described with reference to a single-tube or straight tubular implant 10 is generally similar for the bifurcate or Y-form of FIGS. 3 to 6. For this divided or plural tube form a special conformant mandrel is provided, indicated as a whole at 35, shown separately on a smaller scale in FIG. 6, in disassembled or preparatory condition in FIG. 5 and in use in FIGS. 3 and 4.

It will be understood that bifurcate implants 20, FIGS. 3 and 4, are useful for replacement of vascular junctures, especially that of the large abdominal aorta and its division into the iliac limbs. Such Y-form implant 20 accordingly is formed with a stem or aortic portion 21 usually of relatively larger diameter and having at one endthe iliac branches or legs 22, 22.

The plural-ply tubular fabric blank for this bifurcate form 20 is woven of the synthetic multi-filament warp and filling yarns in similar manner as already explained. Each of the woven tubular portions 21, 22, 22 is structurally similar to that of the single-tube implant of FIGS. 1 and 2 and as represented in detail in FIGS. 7 and 8 with the added feature of the branching and angling tubular structure. Thus in weaving the iliac legs 22 and the crotch or juncture thereof with the aortic stem 21, there is effected a calculated changing of the location of the cross-over lines of union S, S and S in the fillingwise direction for each pick or a small number of picks in each of the two plies. Under the patterned control of the shedding the legs 22, 22 are accorded the desired diameter and angular relation and the crotch area including the extreme point of the Y is integrally woven as a closed fabric structure of equal density with that at all other fabric areas, such that undesired leakage at the bifurcation point and adjacent region is obviated.

The bifurcate mandrel 35, FIGS. 3 to 6, is of similar composition and dimensioning relative to the implant blanks as described in connection with FIGS. 1 and 2. In this instance however it is so articulated that the stem section 36 and one or both'leg sections 37, 37 are relatively detachable. While for some uses one leg 37 may be integral with the stem 36, it is found generally preferable that both legs be demountable as shown.

separability is herein afforded as by provision of interconnecting plug and socket formations at the joints of the mating mandrel sections. In the illustrated example the stem 36 has at the end adjacent and containing the point of leg branching an appropriately flared and correspondingly flattened yoke 36a. Longitudinal sockets 38, 38 are let in from the transverse end wall of the yoke 36a, the sockets being relatively inclined at the angle desired for the mandrel legs 37. The socketed areas of the end wall of the yoke 36a are preferably disposed to be accurately perpendicular to the leg axes. At the proximate ends the mandrel legs 37, 37 are reduced to provide pins 39, .39 adapted for tight seating in the corresponding sockets 38, 38. The parts are accurately machined and finished so that the leg shoulders at the base of the pins tightly abut the end wall of the stem yoke 36a and the cylindrical outer walls of the legs flow substantially without interruption into the circumferential surface of the stem 36 and its yoke 36a. The flattening of the latter across the flared portion is made to compensate for the flare; that is, the circumference at the yoke 36a is kept at or not materially greater than for the main cylindrical portion of the stem 36 so that little or no distention of the tubular fabric blank occurs in the micro-crimping operation.

For vascular implant purposes the iliac legs of a Y-form implant generally are each smaller in diameter than that of the aortic stem but in the practice of the invention they may approach or substantially equal that of the aortic stem. In some instances it is required that the two legs differ in diameter from each other in which case the Y- form tubular blanks are woven to the desired diameters.

Examples of diameter values for bifurcate implants fabricated under the invention include the following in actual practice:

TUBULAR BIFURCATIONS Aortic lliac Flat Open Flat Open Diameter, Diameter, Diameter, Diameter,

22. 3 14. 6 15. 3 10.0 29. 9 19. 0 18. 3 l2. 4 44. 6 28. 7 23.1 15.2 44. 6 28. 7 39. 5 and 23. 4 27.6 and 15.8 52. 2 33. 3 23. 1 l5. 8 52. 2 33. 7 30. 3 19. 4 59. 8 38. 3 23. 4 15.0 59. 8 38. 2 31.0 20.0 37. 6 24. 0 18.7 11.8

The open diameter values in the above table are also the diameter of the corresponding mandrels at room temperature.

As in the case of the single-tube implants the Y-form mandrel diameters, for the aortic stem 36 and for the ili-ac legs 37, 37, are scaled to have at room temperature diameter sizes the same as the lumen or open diameter values such as above indicated. It is noted that implant item No. 4 of the above table has iliac limbs differing from each other in diameter; also that implant items Nos. 5 and 6 and also Nos. 7 and 8 show instances of a given same size of aortic stem available with diflerent sizes of legs.

In any instance the bifurcate mandrels such as 35 are accurately scaled as to stem and leg diameter to that desired for the particular implant. And in any instance the mandrels 35 are so constructed, having reference to the leg diameters relative to the stem and to each other that the two legs are sufiiciently spaced at the point of juncture with the mandrel stern so that the tubular fabric of the respective legs can be compressively installed fully to the end wall of the stem yoke 36a.

In the compressive installation of a Y- form implant blank 20A onto a mandrel 35 the procedure is generally similar as described with respect to the straight form blank of FIGS. 1 and 2. Where 'bot-h mandrel legs are demountable the legs of the fabric blank may be brought onto them in either direction accordingly as the blank stem is installed before or after the blank legs. More conveniently the blank stem is first compressed onto the mandrel stem 36 at the yoke end 36a of the latter and the mandrel legs 37, 37 then inserted through the blank legs, set into the stem sockets 38 and the compressive microcrimpi-ng completed for the entire blank. Obviously with one mandrel leg integral the fabric blank is installed by first passing the stem of the blank over the integral leg of the mandrel.

The operation of mounting the blank on the mandrel again is accomplished with attendant axial compression such that the blank is reduced to the approximate 25% of the overall initial length. In the area of the crotch at the junction of the legs with the stem the micro-crimping is substantially continuous, with the innermost pleats 15 of the leg members merging directly into the pleats 15a of the stem, with the fabric of the first stem pleat brought radially inward central-1y between the legs into conformity with the end wall of the stem yoke 36a and affording crotch-closing fillets uniting all three tubular elements of the implant. Such fillet or crotch-closing wall portion is seen at 23, FIGS. 3 and 4. It has a general hour-glass shape corresponding to the central inter-socket area 36x of the mandrel yoke 36a, FIG. 5.

By way of additional precaution at the area of maximum vulnerability to leakage under abnormal conditions, the Y-form implants 20 after being thoroughly dried following the processing as described in connection with FIGS. 1 and 2 are coated at the crotch area with an aqueous solution of polyvinyl and allowed to air dry. Thereafter the coated area is cured as by placing the implant in an oven at about 250 F for a period to average about five minutes.

The prosthetic implants and 20* as herein disclosed possess such flexibility and resilience that they are free of kink-ing, objectionable stricture or collapse not only under ilexure of the shorter lengths of cm. and cm. through a full 360 of bend but such length can be tied into a throw-knot or given a full twist between the ends and will still maintain an open lumen. They possess the further advantage among others that they can be supplied not only as units fashioned to exact surgical specifications but also in extra or indefinite lengths for cutting to proper lengths in the operating room. Likewise an implant of specified length may if required be extended axially for additional attaching length even in the course of operative implantation.

The resultant vascular implants of the invention and under the method thereof are showing execllent results both in animal and in clinical work in which they have been used to replace segments of the aorta and/ or peripheral arteries, or as shunts, thereby importantly contributing to progress in the field of cardiovascular surgery.

It will be understood that my invention, either as to product, means or method is not limited to the exemplary embodiments or steps herein illustrated or described, and I set forth its scope in my following claims.

What is claimed is:

1. The process for making prosthetic vascular implants which comprises weaving a tubular blank of multifilament syntheic warp and filling yarns, moistening and passing the woven blank onto a cylindrical heat-expansible mandrel of full filling diametral size, progressively axially compressing the blank thereon and simultaneously creating a longitudinal array of circumferential pleat-forming crimps of maximum external projective extent less than a radius of the tube and compacting contiguous crimps into general touching relation of the radial walls thereof for forming the blank into an externally micro-crimped implant tube of approximately one-fourth the initial blank 8 length, heating the assembly of mandrel-carried microcrimped implant in the presence of moisture, cooling said assembly and removing the mandrel, and drying the resultant tubular implant.

2. In the manufacture of vascular prostheses the process comprising the steps of weaving a plural-ply integral tubular body of fine denier synthetic multi-filament warp and filling yarns forming a thin dense flexible fabric of determined low porosity, moistening and passing the Woven tubular body onto a smooth hard-surfaced cylindrical mandrel of lumen-filling diameter, in the presence of moisture axially compressing the body on the mandrel to about one quarter the initial woven length so as to form externally a closely laterally compacted random array of radial pleats and internally a like number of adjoined rings interconnecting adjacent pleats, subjecting the mandrel-carried pleated implant to ironing heat for affording a smooth cylindrical internal wall surface in the implant operatively continuous axially in the non-stretched status of the implant, and then cooling the same, removing the implant from the mandrel and drying it at room temperature.

3. In the manufacture of prosthetic vascular implants wherein textile yarns are interlaced for the fashioning of a circumferentially and longitudinally continuous tubular fabric body as the fabric thereof is fashioned, the process which comprises the steps of watermoistening and passing a length of such tubular fabric body with the fabric thereof otherwise in condition as fashioned onto a cylindrical heat-expansible mandrel of full filling diametral size of the fabric body, progressively axially compressing the fabric body on the mandrel into an externally micro-crimped implant tube of a minor fraction of the initial fabric body length by forming the wall thereof into a multiplicity of external radially short circular pleats of micro-crimping in laterally contactive array along the tube, expansively heating the mandrel with the microcrimped implant tube thereon in the presence of moisture thereby to provide a substantially uninterrupted smooth cylindrical interior surface for said tube, cooling and removing the mandrel, and drying the resultant tubular implant to present a self-shape-maintaining flexible resilient and axially elastic tubular implant having a smooth cylindrical internal wall surface as presented by a multiplicity of laterally conjoined fabric rings spanning between external pleats.

References Cited in the file of this patent UNITED STATES PATENTS 746,630 Greenfield Dec. 8, 1903 1,470,707 Bates Oct. 16, 1923 2,250,261 Goldsmith July 22, 1941 2,780,274 Roberts et al. Feb. 5, 1957 2,836,181 Tapp May 27, 1958 2,845,959 Sidebotbam Aug. 5, 1958 2,897,603 Behrman Aug. 4, 1959 2,990,287 Demsyk July 4, 1961 OTHER REFERENCES Annals of Surgery, Oct. 1955, vol. 142, No. 4, pages 624-632.

Edwards et al.: Surgery, Gynecology and Obstetrics, July, 1958, vol. 107, 62-68.

Citas de patentes
Patente citada Fecha de presentación Fecha de publicación Solicitante Título
US746630 *29 Abr 19038 Dic 1903Edwin T GreenfieldArmored hose and method of making same.
US1470707 *12 Oct 192216 Oct 1923Allen Bates SamuelSurgical appliance
US2250261 *21 Oct 193922 Jul 1941Bertram J GoldsmithNarrow tubular fabric
US2780274 *1 Dic 19555 Feb 1957Fred T RobertsMethod of making flexible corrugated hose
US2836181 *17 Ene 195527 May 1958Chemstrand CorpFlexible nylon tube and method for preparing same
US2845959 *26 Mar 19565 Ago 1958Sidebotham John BBifurcated textile tubes and method of weaving the same
US2897603 *24 Abr 19584 Ago 1959Elza BehrmanFlexible, extensible, and collapsible textile fabric tube
US2990287 *6 Jun 195727 Jun 1961Mealpack CorpApparatus for storing and serving foods
Citada por
Patente citante Fecha de presentación Fecha de publicación Solicitante Título
US3304557 *28 Sep 196521 Feb 1967Ethicon IncSurgical prosthesis
US3669157 *1 Jun 197013 Jun 1972Carolina Narrow Fabric CoShrinkable tubular fabric
US3878565 *25 Jul 197322 Abr 1975Providence HospitalVascular prosthesis with external pile surface
US4191218 *28 Abr 19784 Mar 1980Albany International Corp.Fabrics for heart valve and vascular prostheses and methods of fabricating same
US4193137 *6 May 197718 Mar 1980Meadox Medicals, Inc.Warp-knitted double-velour prosthesis
US4487567 *24 Mar 198311 Dic 1984Possis Medical, Inc.Apparatus for making a vascular graft
US4546499 *13 Dic 198215 Oct 1985Possis Medical, Inc.Method of supplying blood to blood receiving vessels
US4562597 *29 Abr 19837 Ene 1986Possis Medical, Inc.Method of supplying blood to blood receiving vessels
US4601718 *13 Jul 198422 Jul 1986Possis Medical, Inc.Vascular graft and blood supply method
US4652263 *20 Jun 198524 Mar 1987Atrium Medical CorporationElasticization of microporous woven tubes
US4915893 *15 Jul 198310 Abr 1990Medtronic, Inc.Method of preparing polyester filament material
US4983240 *26 Abr 19898 Ene 1991Kamatics CorporationMethod of making a flanged braided bearing
US5110852 *27 Oct 19885 May 1992Rijksuniversiteit Te GroningenFilament material polylactide mixtures
US5178630 *26 May 199212 Ene 1993Meadox Medicals, Inc.Ravel-resistant, self-supporting woven graft
US5282846 *29 Abr 19921 Feb 1994Meadox Medicals, Inc.Ravel-resistant, self-supporting woven vascular graft
US5282848 *19 Abr 19931 Feb 1994Meadox Medicals, Inc.Self-supporting woven vascular graft
US5387300 *27 Ago 19927 Feb 1995Kitamura; AtsushiMethod of manufacturing a seamless tubular woven article including polytetrafluoroethylene yarn
US5487858 *31 Ene 199430 Ene 1996Meadox Medicals, Inc.Process of making self-supporting woven vascular graft
US5489295 *21 May 19936 Feb 1996Endovascular Technologies, Inc.Endovascular graft having bifurcation and apparatus and method for deploying the same
US5496364 *31 Ene 19945 Mar 1996Meadox Medicals, Inc.Self-supporting woven vascular graft
US5509931 *28 Ene 199423 Abr 1996Meadox Medicals, Inc.Ravel-resistant self-supporting woven vascular graft
US5824039 *19 Ene 199620 Oct 1998Endovascular Technologies, Inc.Endovascular graft having bifurcation and apparatus and method for deploying the same
US5824047 *11 Oct 199620 Oct 1998C. R. Bard, Inc.Vascular graft fabric
US5922022 *31 Dic 199713 Jul 1999Kensey Nash CorporationBifurcated connector system for coronary bypass grafts and methods of use
US6015431 *23 Dic 199618 Ene 2000Prograft Medical, Inc.Endolumenal stent-graft with leak-resistant seal
US6077296 *4 Mar 199820 Jun 2000Endologix, Inc.Endoluminal vascular prosthesis
US6090128 *20 Feb 199718 Jul 2000Endologix, Inc.Bifurcated vascular graft deployment device
US6117117 *24 Ago 199812 Sep 2000Advanced Cardiovascular Systems, Inc.Bifurcated catheter assembly
US6156063 *28 May 19985 Dic 2000Endologix, Inc.Method of deploying bifurcated vascular graft
US6165195 *13 Ago 199726 Dic 2000Advanced Cardiovascylar Systems, Inc.Stent and catheter assembly and method for treating bifurcations
US618703611 Dic 199813 Feb 2001Endologix, Inc.Endoluminal vascular prosthesis
US619704917 Feb 19996 Mar 2001Endologix, Inc.Articulating bifurcation graft
US62103804 Abr 20003 Abr 2001Advanced Cardiovascular Systems, Inc.Bifurcated catheter assembly
US621042216 Feb 20003 Abr 2001Endologix, Inc.Bifurcated vascular graft deployment device
US621043517 Ago 19993 Abr 2001Endovascular Technologies, Inc.Endovascular graft having bifurcation and apparatus and method for deploying the same
US621403815 Sep 199910 Abr 2001Endovascular Technologies, Inc.Method for deploying an endovascular graft having a bifurcation
US622109023 Sep 199924 Abr 2001Advanced Cardiovascular Systems, Inc.Stent delivery assembly
US62210989 Dic 199924 Abr 2001Advanced Cardiovascular Systems, Inc.Stent and catheter assembly and method for treating bifurcations
US625459310 Dic 19993 Jul 2001Advanced Cardiovascular Systems, Inc.Bifurcated stent delivery system having retractable sheath
US626131611 Mar 199917 Jul 2001Endologix, Inc.Single puncture bifurcation graft deployment system
US62646825 Oct 199924 Jul 2001Advanced Cardiovascular Systems, Inc.Stent and catheter assembly and method for treating bifurcations
US63311889 Jun 199718 Dic 2001Gore Enterprise Holdings, Inc.Exterior supported self-expanding stent-graft
US633119014 Ene 200018 Dic 2001Endologix, Inc.Endoluminal vascular prosthesis
US635255318 Jul 19975 Mar 2002Gore Enterprise Holdings, Inc.Stent-graft deployment apparatus and method
US635256123 Dic 19965 Mar 2002W. L. Gore & AssociatesImplant deployment apparatus
US63615441 Dic 199926 Mar 2002Advanced Cardiovascular Systems, Inc.Stent and catheter assembly and method for treating bifurcations
US636155515 Dic 199926 Mar 2002Advanced Cardiovascular Systems, Inc.Stent and stent delivery assembly and method of use
US636163713 Ago 199926 Mar 2002Gore Enterprise Holdings, Inc.Method of making a kink resistant stent-graft
US63719788 May 200116 Abr 2002Advanced Cardiovascular Systems, Inc.Bifurcated stent delivery system having retractable sheath
US638321324 Mar 20017 May 2002Advanced Cardiovascular Systems, Inc.Stent and catheter assembly and method for treating bifurcations
US638712026 Abr 200114 May 2002Advanced Cardiovascular Systems, Inc.Stent and catheter assembly and method for treating bifurcations
US642856724 Abr 20016 Ago 2002Advanced Cardiovascular Systems, Inc.Stent and catheter assembly and method for treating bifurcations
US647520822 Ene 20015 Nov 2002Advanced Cardiovascular Systems, Inc.Bifurcated catheter assembly
US64948758 Sep 200017 Dic 2002Advanced Cardiovascular Systems, Inc.Bifurcated catheter assembly
US650020215 Mar 200031 Dic 2002Endologix, Inc.Bifurcation graft deployment catheter
US650883528 Nov 200021 Ene 2003Endologix, Inc.Endoluminal vascular prosthesis
US650883614 Jun 200121 Ene 2003Advanced Cardiovascular Systems, Inc.Stent and catheter assembly and method for treating bifurcations
US651757021 Jul 199711 Feb 2003Gore Enterprise Holdings, Inc.Exterior supported self-expanding stent-graft
US652098626 Jun 200118 Feb 2003Gore Enterprise Holdings, Inc.Kink resistant stent-graft
US654421915 Dic 20008 Abr 2003Advanced Cardiovascular Systems, Inc.Catheter for placement of therapeutic devices at the ostium of a bifurcation of a body lumen
US657931214 Jun 200117 Jun 2003Advanced Cardiovascular Systems, Inc.Stent and catheter assembly and method for treating bifurcations
US658239414 Nov 200024 Jun 2003Advanced Cardiovascular Systems, Inc.Stent and catheter assembly and method for treating bifurcated vessels
US659931520 Nov 200129 Jul 2003Advanced Cardiovascular Systems, Inc.Stent and stent delivery assembly and method of use
US661307218 Jul 19972 Sep 2003Gore Enterprise Holdings, Inc.Procedures for introducing stents and stent-grafts
US666003022 Dic 20009 Dic 2003Endologix, Inc.Bifurcation graft deployment catheter
US666366528 Feb 200116 Dic 2003Endologix, Inc.Single puncture bifurcation graft deployment system
US66731076 Dic 19996 Ene 2004Advanced Cardiovascular Systems, Inc.Bifurcated stent and method of making
US670944011 Jul 200223 Mar 2004Advanced Cardiovascular Systems, Inc.Stent and catheter assembly and method for treating bifurcations
US673352326 Jun 200111 May 2004Endologix, Inc.Implantable vascular graft
US674962817 May 200115 Jun 2004Advanced Cardiovascular Systems, Inc.Stent and catheter assembly and method for treating bifurcations
US678017416 Dic 200224 Ago 2004Advanced Cardiovascular Systems, Inc.Bifurcated catheter assembly
US680285616 Abr 200212 Oct 2004Advanced Cardiovascular Systems, Inc.Bifurcated stent delivery system having retractable sheath
US687522927 Ene 20035 Abr 2005Advanced Cardiovascular Systems, Inc.Stent and catheter assembly and method for treating bifurcations
US68966998 Oct 200324 May 2005Advanced Cardiovascular Systems, Inc.Stent and catheter assembly and method for treating bifurcations
US695157212 Ago 20034 Oct 2005Endologix, Inc.Bifurcated vascular graft and method and apparatus for deploying same
US695347530 Sep 200311 Oct 2005Endologix, Inc.Bifurcation graft deployment catheter
US695568816 Jul 200318 Oct 2005Advanced Cardiovascular Systems, Inc.Stent and catheter assembly and method for treating bifurcations
US699472415 Nov 20017 Feb 2006Mcmurray Fabrics, Inc.Soft-tissue tubular prostheses with seamed transitions
US709069419 Nov 200315 Ago 2006Advanced Cardiovascular Systems, Inc.Portal design for stent for treating bifurcated vessels
US746531528 Jul 200616 Dic 2008Advanced Cardiovascular Systems, Inc.Portal design for stent for treating bifurcated vessels
US746531612 Abr 200416 Dic 2008Boston Scientific Scimed, Inc.Tri-petaled aortic root vascular graft
US74818377 Oct 200427 Ene 2009Advanced Cardiovascular Systems, Inc.Bifurcated stent delivery system having retractable sheath
US7484539 *3 Dic 20073 Feb 2009Ching Sui Industry Co., Ltd.Shaping method and structure of woven fabric with a groove
US75208958 Abr 200221 Abr 2009Endologix, Inc.Self expanding bifurcated endovascular prosthesis
US76823801 Jul 200223 Mar 2010Gore Enterprise Holdings, Inc.Kink-resistant bifurcated prosthesis
US77539507 Ago 200713 Jul 2010Advanced Cardiovascular Systems, Inc.Stent and catheter assembly and method for treating bifurcations
US775863312 Abr 200420 Jul 2010Boston Scientific Scimed, Inc.Varied diameter vascular graft
US78922773 May 200622 Feb 2011Endologix, Inc.Self expanding bifurcated endovascular prosthesis
US79553797 Ago 20077 Jun 2011Abbott Cardiovascular Systems Inc.Stent and catheter assembly and method for treating bifurcations
US795966721 Dic 200614 Jun 2011Abbott Cardiovascular Systems Inc.Catheter assembly and method for treating bifurcations
US80295587 Jul 20064 Oct 2011Abbott Cardiovascular Systems, Inc.Stent and catheter assembly and method for treating bifurcations
US803410025 Nov 200311 Oct 2011Endologix, Inc.Graft deployment system
US811885627 Jul 201021 Feb 2012Endologix, Inc.Stent graft
US814753525 Jul 20053 Abr 2012Endologix, Inc.Bifurcation graft deployment catheter
US816792525 Mar 20101 May 2012Endologix, Inc.Single puncture bifurcation graft deployment system
US82162951 Jul 200910 Jul 2012Endologix, Inc.Catheter system and methods of using same
US823604011 Abr 20087 Ago 2012Endologix, Inc.Bifurcated graft deployment systems and methods
US83233289 Sep 20024 Dic 2012W. L. Gore & Associates, Inc.Kink resistant stent-graft
US835719211 Mar 201122 Ene 2013Endologix, Inc.Bifurcated graft deployment systems and methods
US837708013 Abr 201019 Feb 2013Kensey Nash CorporationSurgical connector systems and methods of use
US83886798 Jun 20105 Mar 2013Maquet Cardiovascular LlcSingle continuous piece prosthetic tubular aortic conduit and method for manufacturing the same
US849164615 Jul 201023 Jul 2013Endologix, Inc.Stent graft
US852393112 Ene 20073 Sep 2013Endologix, Inc.Dual concentric guidewire and methods of bifurcated graft deployment
US86230657 Oct 20027 Ene 2014W. L. Gore & Associates, Inc.Exterior supported self-expanding stent-graft
US869674123 Dic 201015 Abr 2014Maquet Cardiovascular LlcWoven prosthesis and method for manufacturing the same
US8741201 *9 Sep 20103 Jun 2014Advanced Cardiovascular Systems, Inc.Fiber reinforced composite stents
US876481218 Ene 20131 Jul 2014Endologix, Inc.Bifurcated graft deployment systems and methods
US880835029 Feb 201219 Ago 2014Endologix, Inc.Catheter system and methods of using same
US882156416 Feb 20122 Sep 2014Endologix, Inc.Stent graft
US883455422 Ago 200616 Sep 2014Abbott Cardiovascular Systems Inc.Intravascular stent
US888282620 Ago 200711 Nov 2014Abbott Cardiovascular Systems Inc.Intravascular stent
US894520228 Abr 20103 Feb 2015Endologix, Inc.Fenestrated prosthesis
US89693536 Nov 20093 Mar 2015Massachusetts Institute Of TechnologyAminoalcohol lipidoids and uses thereof
US900648714 Jun 200614 Abr 2015Massachusetts Institute Of TechnologyAmine-containing lipids and uses thereof
US918132117 Jun 201410 Nov 2015Shire Human Genetic Therapies, Inc.CFTR mRNA compositions and related methods and uses
US9186240 *1 May 201417 Nov 2015Abbott Cardiovascular Systems Inc.Fiber reinforced composite stents
US919382726 Ago 201124 Nov 2015Massachusetts Institute Of TechnologyPoly(beta-amino alcohols), their preparation, and uses thereof
US922791725 Nov 20135 Ene 2016Massachusetts Institute Of TechnologyAmine-containing lipidoids and uses thereof
US923871623 Mar 201219 Ene 2016Massachusetts Institute Of TechnologyConjugated lipomers and uses thereof
US930828118 Jun 201412 Abr 2016Shire Human Genetic Therapies, Inc.MRNA therapy for Fabry disease
US93154721 May 201419 Abr 2016Massachusetts Institute Of Technology1,3,5-triazinane-2,4,6-trione derivatives and uses thereof
US939310016 Nov 201119 Jul 2016Endologix, Inc.Devices and methods to treat vascular dissections
US940275322 Dic 20112 Ago 2016Maquet Cardiovascular LlcWoven prosthesis and method for manufacturing the same
US94399684 Ene 201613 Sep 2016Massachusetts Institute Of TechnologyAmine-containing lipidoids and uses thereof
US952217622 Oct 201420 Dic 2016Shire Human Genetic Therapies, Inc.MRNA therapy for phenylketonuria
US954983518 Ago 201424 Ene 2017Endologix, Inc.Catheter system and methods of using same
US955611016 Ene 201531 Ene 2017Massachusetts Institute Of TechnologyAminoalcohol lipidoids and uses thereof
US957910330 Abr 201028 Feb 2017Endologix, Inc.Percutaneous method and device to treat dissections
US959741318 Jun 201421 Mar 2017Shire Human Genetic Therapies, Inc.Pulmonary delivery of mRNA
US962980422 Oct 201425 Abr 2017Shire Human Genetic Therapies, Inc.Lipid formulations for delivery of messenger RNA
US968737414 Dic 201627 Jun 2017Endologix, Inc.Catheter system and methods of using same
US97007019 Jul 201211 Jul 2017Endologix, Inc.Catheter system and methods of using same
US97136266 Oct 201525 Jul 2017Rana Therapeutics, Inc.CFTR mRNA compositions and related methods and uses
US975726216 Jul 201312 Sep 2017Endologix, Inc.Stent graft
US20020111675 *16 Abr 200215 Ago 2002Wilson W. StanBifurcated stent delivery system having retractable sheath
US20020165602 *8 Abr 20027 Nov 2002Douglas Myles S.Self expanding bifurcated endovascular prosthesis
US20020165603 *1 Jul 20027 Nov 2002Troy ThorntonKink-resistant bifurcated prosthesis
US20030093109 *16 Dic 200215 May 2003Mauch Kevin M.Bifurcated catheter assembly
US20040138735 *21 Oct 200315 Jul 2004Shaolian Samuel M.Single puncture bifurcation graft deployment system
US20040204753 *12 Ene 200414 Oct 2004Shokoohi Mehrdad M.Endoluminal vascular prosthesis
US20050043779 *7 Oct 200424 Feb 2005Wilson W. StanBifurcated stent delivery system having retractable sheath
US20050228487 *12 Abr 200413 Oct 2005Scimed Life Systems, Inc.Tri-petaled aortic root vascular graft
US20050228488 *12 Abr 200413 Oct 2005Scimed Life Systems, Inc.Varied diameter vascular graft
US20050273154 *8 Jun 20048 Dic 2005Colone William MBifurcated stent graft and apparatus for making same
US20060265050 *28 Jul 200623 Nov 2006Grayson MorrisPortal design for stent for treating bifurcated vessels
US20060271163 *3 May 200630 Nov 2006Shokoohi Mehrdad MEndoluminal vascular prosthesis
US20060287713 *3 May 200621 Dic 2006Douglas Myles SSelf expanding bifurcated endovascular prosthesis
US20070071685 *21 Dic 200429 Mar 2007Bracco Research S.A.Gas-filled microvesicle assembly for contrast imaging
US20070112412 *16 Ene 200717 May 2007Endologix, Inc.Endoluminal vascular prosthesis
US20080009829 *30 Jul 200710 Ene 2008Abbott Cardiovascular Systems Inc.Balloon catheter having a branched distal section with secured branches
US20080009932 *7 Jul 200610 Ene 2008Diem Uyen TaStent and catheter assembly and method for treating bifurcations
US20080009933 *21 Dic 200610 Ene 2008Diem Uyen TaCatheter assembly and method for treating bifurcations
US20080051876 *20 Ago 200728 Feb 2008Advanced Cardiovascular Systems, Inc.Intravascular stent
US20080086190 *22 Ago 200610 Abr 2008Diem Uyen TaIntravascular stent
US20080300602 *3 Mar 20084 Dic 2008Schmitt Peter JFabric medical device having a tapered transition and method of making
US20090012601 *5 Jul 20078 Ene 2009Abbott Cardiovascular Systems, Inc.Stent and catheter assembly and method for treating bifurcations
US20090105806 *23 Oct 200823 Abr 2009Endologix, IncStent
US20090138066 *30 Ene 200928 May 2009Leopold Eric WImplant Deployment Apparatus
US20100217290 *13 Abr 201026 Ago 2010Nash John ESurgical connector systems and methods of use
US20110009641 *14 Jun 200613 Ene 2011Anderson Daniel GAmine-containing lipids and uses thereof
US20110009948 *9 Sep 201013 Ene 2011Advanced Cardiovascular Systems, Inc.Fiber Reinforced Composite Stents
US20110054587 *28 Abr 20103 Mar 2011Endologix, Inc.Apparatus and method of placement of a graft or graft system
US20140242257 *1 May 201428 Ago 2014Abbott Cardiovascular Systems Inc.Fiber reinforced composite stents
US20170021141 *13 May 201626 Ene 2017Cook Medical Technologies LlcVariable diameter woven medical tube textiles and method of making same
EP0000949A1 *25 Ago 19787 Mar 1979Philip Nicholas SawyerCardiac and vascular prostheses and methods of making the same
EP2075014A227 May 20031 Jul 2009Angiotech International AgCompositions and methods for coating medical implants
WO1998027893A29 Dic 19972 Jul 1998Prograft Medical, Inc.Kink resistant bifurcated prosthesis
WO1998027895A19 Dic 19972 Jul 1998Prograft Medical, Inc.Endolumenal stent-graft with leak-resistant seal
WO1999065419A128 May 199923 Dic 1999Endologix, Inc.Self expanding bifurcated endovascular prosthesis
WO2000053251A17 Mar 200014 Sep 2000Endologix, Inc.Single puncture bifurcation graft deployment system
WO2003045284A227 Nov 20025 Jun 2003The Research Foundation Of State University Of New YorkEndovascular graft and graft trimmer
WO2003049644A16 Dic 200219 Jun 2003Boston Scientific LimitedAnatomically curved graft for implantation at the aortic arch
WO2005120398A1 *8 Jun 200522 Dic 2005Lemaitre Acquisition LlcBifurcated stent graft and apparatus for making same
Clasificaciones
Clasificación de EE.UU.28/143, 139/387.00R, 28/165, 623/903
Clasificación internacionalA61F2/06
Clasificación cooperativaA61F2002/065, A61F2/06, Y10S623/903
Clasificación europeaA61F2/06